CARDIOMYOPATHY
Clinical trials for CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart MRI showdown: which contrast agent wins?
Diagnosis CompletedThis study tested two different contrast agents (Dotarem and Gadovist) used during heart MRI scans to see if they produce equally clear images. 120 adults with coronary artery disease or cardiomyopathy were randomly assigned to receive one of the two agents. The goal was to compa…
Matched conditions: CARDIOMYOPATHY
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Diagnosis
Last updated May 18, 2026 12:12 UTC
-
Heart drug fails to protect duchenne boys from cardiac decline
Prevention CompletedThis study tested whether nebivolol, a beta-blocker, could prevent heart problems in 51 boys aged 10–15 with Duchenne muscular dystrophy. Participants had healthy hearts at the start and were randomly given either the drug or a placebo. The goal was to see if the drug could stop …
Matched conditions: CARDIOMYOPATHY
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Prevention
Last updated May 19, 2026 11:47 UTC
-
Healthy volunteers test new heart Drug's absorption and food effects
Knowledge-focused CompletedThis completed Phase I study involved 38 healthy adults to compare two different tablet forms of HRS-1893, a drug for cardiomyopathy, and to see how food changes the way the body absorbs the drug. Researchers measured drug levels in the blood and monitored safety. The study does …
Matched conditions: CARDIOMYOPATHY
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 08:20 UTC
-
Gene study seeks clues to inflammation and disease risk
Knowledge-focused CompletedThis study looked at how certain genes in blood cells respond to environmental exposures, which may help explain why some people develop inflammation, cancer, or heart problems. Researchers collected blood samples from 178 healthy volunteers aged 18 to 45. The goal was to underst…
Matched conditions: CARDIOMYOPATHY
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC
-
AI-Powered mobile ECG could spot hidden heart disease in families
Knowledge-focused CompletedThis study tested whether a simple, portable ECG device connected to a smartphone could help screen close relatives of people with dilated cardiomyopathy (a weakened heart muscle). 119 adults participated, including patients and their first-degree relatives. The goal was to see h…
Matched conditions: CARDIOMYOPATHY
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 19, 2026 11:59 UTC
-
Heart failure mystery solved? Beta-Blockers' secret revealed
Knowledge-focused CompletedThis study looked at how beta-blocker medicines improve heart function in people with heart failure. Researchers measured changes in the heart's ability to contract and pump blood. The goal was to understand the underlying mechanisms, not to test a new treatment. 55 adults with n…
Matched conditions: CARDIOMYOPATHY
Phase: PHASE4 • Sponsor: Michael E. DeBakey VA Medical Center • Aim: Knowledge-focused
Last updated May 18, 2026 12:08 UTC